Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock PHARMIDEX PHARMACEUTICAL SERVICES LIMITED's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LitePHARMIDEX PHARMACEUTICAL SERVICES LIMITED
167-169 GREAT PORTLAND STREET, FIFTH FLOOR, LONDON, W1W 5PF
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Private limited with Share Capital
Active - Accounts Filed
17 May 2002
72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology
Available to 29 Apr 2026. Next accounts due by 31 Mar 2027
Is PHARMIDEX PHARMACEUTICAL SERVICES LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| A2E CAPITAL PARTNERS LIMITED | Director | ||
| Professor Mohammad Sadeghi-Alavijeh | Director | ||
| Professor Mohammad Sadeghi-Alavijeh | Company Secretary |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
1
Total Satisfied
7
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Flexicare (Group) Limited | OUTSTANDING | |||
| Deed Of Variation Relating To A Mortgage Debenture Dated 19 January 2011 | Mohammed Alavijeh | SATISFIED | ||
| Deed Of Variation Relating To A Mortgage Debenture Dated 19 January 2011 | Flexicare Medical Limited (The Creditor) | SATISFIED | ||
| Deed Of Variation Relating To A Mortgage Debenture Dated 19 January 2011 | E2e Venture Catalysts Limited (The Creditor) | SATISFIED | ||
| Mortgage Debenture | Flexicare Medical Limited | SATISFIED | ||
| Mortgage Debenture | Mohammed Alavijeh | SATISFIED | ||
| Mortgage Debenture | A2e Venture Catalysts Limited | SATISFIED | ||
| Debenture | The Governor And Company Of The Bank Of Scotland | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £435,708.00 | £208,755.00 | £90,681.00 | £81,798.00 | £123,613.00 |
| Net Worth | £1,792,468.00 | £1,588,856.00 | £476,776.00 | £603,381.00 | £337,778.00 |
| Total Current Liabilities | £1,772,039.00 | £1,640,550.00 | £2,078,395.00 | £1,855,202.00 | £1,450,936.00 |
| Total Current Assets | £1,895,389.00 | £1,971,306.00 | £1,545,248.00 | £1,487,208.00 | £1,484,991.00 |
Frequently Asked Questions about PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Detailed answers about PHARMIDEX PHARMACEUTICAL SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMIDEX PHARMACEUTICAL SERVICES LIMITED founded?
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED was officially incorporated on 17 May 2002 and is registered under company number 04441512. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMIDEX PHARMACEUTICAL SERVICES LIMITED?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMIDEX PHARMACEUTICAL SERVICES LIMITED?
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMIDEX PHARMACEUTICAL SERVICES LIMITED do?
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED operates in the following sector: 72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is PHARMIDEX PHARMACEUTICAL SERVICES LIMITED's registered address?
The registered office address of PHARMIDEX PHARMACEUTICAL SERVICES LIMITED is 167-169, Great Portland Street, London, Westminster, W1W 5PF. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMIDEX PHARMACEUTICAL SERVICES LIMITED financially stable?
Based on the latest accounts up to 29 Apr 2026, PHARMIDEX PHARMACEUTICAL SERVICES LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 Mar 2027. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.